Results 131 to 140 of about 169,918 (164)

[Correlation between trimethylamine-N-oxide and cardiovascular metabolic markers]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Zhang H   +18 more
europepmc   +1 more source

大豆蛋白複合配方產品之調節血脂功能評估

open access: yes
本研究使用大豆蛋白、鈣等材料,設計一大豆蛋白複合配方作為樣品,在倉鼠模式下探討樣品調節血脂之能力,將倉鼠分成5組,餵予普通飼料(C)、高脂飼料(HF) (含14%油脂、0.2%膽固醇)及添加低(0.5X)、中(1X)及高(2X)劑量樣品之高脂飼料共8週。 實驗結果顯示,相較於高脂飼料組(HF),中劑量(1X)與高劑量(2X)組可顯著(p < 0.05)降低血清三酸甘油酯濃度約22-24%,血清總膽固醇濃度下降約15-22%,血清低密度脂蛋白膽固醇濃度減少約26-37%,此外,與高脂控制組(HF)相比 ...
Zhi-Yi Yu, 余芝儀
core  

[Schisandrin A alleviates neuronal ferroptosis in mice with hypoxic-ischemic brain injury by inhibiting the ACSL4/TFRC/PTGS2 signaling pathway]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Guo T   +8 more
europepmc   +1 more source

[Proportion and clinical characteristics of probable metabolic-associated fatty liver disease-related cirrhosis in cryptogenic cirrhosis]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Wang Y   +7 more
europepmc   +1 more source

[Across-sectional study on the association between steatotic liver disease and its subtypes, cardiovascular health status, and extrahepatic comorbidity]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Guan JB   +8 more
europepmc   +1 more source

[Noninvasive scores for predicting liver-related events in patients with metabolic dysfunction-associated fatty liver disease]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Gao YK   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy